Soleno Therapeutics to Participate in Piper Sandler 36th Annual Healthcare Conference


REDWOOD CITY, Calif., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that management will participate in a fireside chat at the Piper Sandler 36th Annual Healthcare Conference on Thursday, December 5, 2024, at 9:00 AM Eastern Time.

Read the rest here:
Soleno Therapeutics to Participate in Piper Sandler 36th Annual Healthcare Conference

Related Posts